Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
Canadian Advanced Parkinson DUODOPA-Treated Patients Observational Study Evaluating Long-Term Health Outcomes in Centers of Excellence (CADENCE)
Sponsor: AbbVie
A observational or N/A phase clinical study on Parkinson Disease (PD), this trial is completed. The trial is conducted by AbbVie and has accumulated 16 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Sep 2021 [monthly]
Completed
▶ Show 11 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
May 2019 — Mar 2020 [monthly]
Recruiting
-
Jan 2019 — May 2019 [monthly]
Recruiting
-
Sep 2018 — Jan 2019 [monthly]
Recruiting
-
Jul 2018 — Sep 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Recruiting NA
-
Feb 2017 — Nov 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Oct 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AbbVie
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Calgary, Canada , Edmonton, Canada , Hamilton, Canada , Kingston, Canada , London, Canada , Montreal, Canada , Ottawa, Canada , Québec, Canada , Sherbrooke, Canada , Toronto, Canada and 1 more location